Arteritis: Clinical Trials

8 trials for Arteritis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 unknown. 8 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 28Unknown 8
Phase 31Unknown 1

Follow Arteritis: new trials by email Literature Review of Arteritis trials Research Report on Arteritis

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Methotrexate as Remission Maintenance Therapy After Remission-Induction With Tocilizumab and Glucocorticoids in Giant Cell Arteritis
Methotrexate, Sodium chloride - Giant Cell Arteritis
Phase 2UnknownUniversity of Bonn522022-11-232024-04-10
Efficacy of Tocilizumab for the Treatment of Acute AION Related to GCA
tocilizumab and IV steroids combination, IV steroids combination alone - Giant Cell Arteritis, Optic Ischaemic Neuropathy
Phase 2UnknownCentre Hospitalier National d'Ophtalmologie des Quinze-Vingts582020-09-102022-03-18
Multicentre, Randomized, Prospective Trial Evaluating the Efficacy and Safety of Infliximab to Tocilizumab in Refractory or Relapsing Takayasu Arteritis
Infliximab, Tocilizumab - Takayasu Arteritis
Phase 2UnknownAssistance Publique - Hôpitaux de Paris502020-09-012020-09-25
Inflammation Reduction by TREhalose AdminisTration
Trehalose, Normal saline - Acute Coronary Syndrome
Phase 2UnknownMashhad University of Medical Sciences152020-08-202020-09-21
Anti-inflammatory Treatment for Inactive Takayasu Arteritis
Prednisone, cyclophosphamide - Takayasu Arteritis, Anti-Inflammatory Agents
Phase 2 / Phase 3UnknownChinese Academy of Medical Sciences, Fuwai Hospital402018-06-012018-06-08
Clinical Study of Anti-tumor Necrosis Factor Therapy in Patients With Takayasu Arteritis
remicade (anti tumor necrosis factor inhibitor) - Takayasu's Arteritis
Phase 2UnknownSeoul National University Hospital112015-03-012017-05-15
Comparison of Two Under Knee Lower Limb Bypass Types:Endothelialised Prosthesis Versus Autologous Vein Graft
endothelialised prosthesis - Arteritis
Phase 2UnknownUniversity Hospital, Bordeaux402004-06-012005-09-22
Cyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing Vasculitides
Methotrexate, Cyclophosphamide - Wegener's Granulomatosis, Churg-Strauss Syndrome
Phase 2UnknownUniversity of Parma2008-09-12

Narrower conditions

Takayasu Arteritis (3)  ·  Giant Cell Arteritis (2)  ·  Vasculitis (2)  ·  Acute Coronary Syndrome (1)  ·  Churg-Strauss Syndrome (1)  ·  Granulomatosis with Polyangiitis (1)  ·  Microscopic Polyangiitis (1)  ·  Optic Neuropathy, Ischemic (1)  ·  Polyarteritis Nodosa (1)  ·  Rheumatic Diseases (1)

Broader conditions

Cardiovascular Diseases (8)  ·  Vascular Diseases (8)  ·  Skin Diseases (6)  ·  Skin Diseases, Vascular (6)  ·  Skin and Connective Tissue Diseases (6)  ·  Vasculitis (6)  ·  Aortic Arch Syndromes (3)  ·  Aortic Diseases (3)  ·  Autoimmune Diseases (3)  ·  Brain Diseases (3)  ·  Central Nervous System Diseases (3)  ·  Cerebrovascular Disorders (3)  ·  Immune System Diseases (3)  ·  Nervous System Diseases (3)

Interventions

Cyclophosphamide (2)  ·  Infliximab (2)  ·  Methotrexate (2)  ·  Sodium Chloride (2)  ·  tocilizumab (2)  ·  CT-P13 (1)  ·  Prednisone (1)  ·  Saline Solution (1)  ·  Trehalose (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts (1)  ·  Chinese Academy of Medical Sciences, Fuwai Hospital (1)  ·  Mashhad University of Medical Sciences (1)  ·  Seoul National University Hospital (1)  ·  University Hospital, Bordeaux (1)  ·  University of Bonn (1)  ·  University of Parma (1)

Countries

France (2)  ·  Germany (1)  ·  Iran (1)  ·  Italy (1)  ·  South Korea (1)

Top investigators

Carlo Buzio, MD (1)  ·  Emmanuel Heron, MD (1)  ·  Jacques Demotes-Mainard, MD-PhD (1)  ·  Laurence Bordenave, MD-PhD (1)  ·  Xiongjing Jiang, MD (1)  ·  Yeong Wook Song, MD,PhD (1)

Results publications

PMID 29016646, PMID 30229280, PMID 38225579

NIH funding

2019 (1)